May Wang
Corporate Officer/Principal presso HUTCHMED (CHINA) LIMITED
Posizioni attive di May Wang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HUTCHMED (CHINA) LIMITED | Corporate Officer/Principal | 01/01/2010 | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 27/07/2011 | - |
Storia della carriera di May Wang
Precedenti posizioni note di May Wang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Formazione di May Wang
| Purdue University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Cina | 2 |
| Hong Kong | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| HUTCHMED (CHINA) LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- May Wang
- Esperienza
